Recruitment

Recruitment Status
Active, not recruiting
Estimated Enrollment
Same as current

Summary

Conditions
  • Cerebral Cavernous Malformation
  • Intracerebral Hemorrhage
Type
Observational
Design
Observational Model: CohortTime Perspective: Prospective

Participation Requirements

Age
Between 18 years and 80 years
Gender
Both males and females

Description

Cerebral cavernous malformation Patients with newly diagnosed, cerebral cavernous malformation who will visit one of the study centers during the period from June 2016 to December 2017. Patients would be eligible for enrollment if they were 18 years of age or older and had at least 1 cerebral cavern...

Cerebral cavernous malformation Patients with newly diagnosed, cerebral cavernous malformation who will visit one of the study centers during the period from June 2016 to December 2017. Patients would be eligible for enrollment if they were 18 years of age or older and had at least 1 cerebral cavernous malformation. If the patient had multiple cavernous malformations, index cavernous malformation would be enrolled. Index lesion will be determined according to the criteria. Index lesion decision criteria I. Symptomatic II. Asymptomatic (priorities are as follows) Previous bleed Brain stem location Deep nuclei (thalamus, caudate, basal ggl, hypothalamus) Periventricular Largest All patients who would visit a study center during the enrollment period and meet these criteria will be asked to join the study. The cohort will consists of patients who agree to participate. Target population of this study is 228 patients.

Tracking Information

NCT #
NCT02946866
Collaborators
  • Asan Medical Center
  • KangWon National University Hospital
  • Jeju National University Hospital
  • Chuncheon Sacred Heart Hospital
  • SMG-SNU Boramae Medical Center
  • Gyeongsang National University Hospital
  • Soonchunhyang University Hospital
  • Johannes Gutenberg University Mainz
  • First Affiliated Hospital of Suzhou Medical College
Investigators
Principal Investigator: JeongEun Kim, MD. PhD. Study Principal Investigator